Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana
- PMID: 17109297
- DOI: 10.1086/508865
Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana
Abstract
In industrialized countries, it is recommended that adults with human immunodeficiency virus type 1 (HIV-1) infection undergo baseline screening for pathogens that might cause latent or active infections, such as syphilis, hepatitis B, hepatitis C, infection due to Toxoplasma gondii, and cytomegalovirus infection. A paucity of data exist from sub-Saharan Africa describing the prevalence of these pathogens. We report data for HIV-1-infected adults referred for initiation of highly active antiretroviral therapy in Botswana.
Similar articles
-
Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.Liver Int. 2005 Apr;25(2):201-13. doi: 10.1111/j.1478-3231.2005.01054.x. Liver Int. 2005. PMID: 15780040 Review.
-
Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy.Clin Infect Dis. 2002 Apr 15;34(8):1146-9. doi: 10.1086/339750. Epub 2002 Mar 19. Clin Infect Dis. 2002. PMID: 11915006
-
Nutrition and HIV/AIDS in sub-Saharan Africa: an overview.Nutrition. 2005 Jan;21(1):96-9. doi: 10.1016/j.nut.2004.09.013. Nutrition. 2005. PMID: 15661483 Review.
-
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.Clin Infect Dis. 2003 Oct 1;37(7):e112-4. doi: 10.1086/378126. Epub 2003 Sep 10. Clin Infect Dis. 2003. PMID: 13130422
-
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.Clin Infect Dis. 2007 Nov 1;45(9):1221-9. doi: 10.1086/522173. Epub 2007 Sep 21. Clin Infect Dis. 2007. PMID: 17918088
Cited by
-
Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.HIV Ther. 2009 Sep 1;3(5):501-526. doi: 10.2217/hiv.09.35. HIV Ther. 2009. PMID: 20161344 Free PMC article.
-
In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa.Arch Virol. 2021 Nov;166(11):3075-3084. doi: 10.1007/s00705-021-05196-7. Epub 2021 Sep 1. Arch Virol. 2021. PMID: 34468889
-
Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana.Pathogens. 2020 Nov 14;9(11):950. doi: 10.3390/pathogens9110950. Pathogens. 2020. PMID: 33202597 Free PMC article.
-
High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana.Open Forum Infect Dis. 2023 Jan 6;10(1):ofac707. doi: 10.1093/ofid/ofac707. eCollection 2023 Jan. Open Forum Infect Dis. 2023. PMID: 36686633 Free PMC article.
-
Importance of nonenteric protozoan infections in immunocompromised people.Clin Microbiol Rev. 2010 Oct;23(4):795-836. doi: 10.1128/CMR.00001-10. Clin Microbiol Rev. 2010. PMID: 20930074 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical